Danaher Corporation (NYSE:DHR) Given Consensus Rating of "Moderate Buy" by Analysts

Key Points

• Danaher Corporation has received a consensus rating of "Moderate Buy", with 17 analysts recommending a buy and 3 recommending a hold, and an average price target of $245.91.
• In its most recent quarter, Danaher reported an EPS of $1.80, surpassing the expected $1.64, along with a revenue of $5.94 billion.
• The company has declared a quarterly dividend of $0.32 per share, representing an annualized yield of 0.7%, to be paid on October 31st.

Danaher Corporation (NYSE:DHR - Get Free Report) has been given an average rating of "Moderate Buy" by the twenty research firms that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation and seventeen have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $245.9130.

DHR has been the subject of several research analyst reports. Robert W. Baird increased their price objective on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. Royal Bank Of Canada set a $241.00 target price on Danaher in a report on Tuesday, September 2nd. Deutsche Bank Aktiengesellschaft cut their price target on shares of Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Guggenheim restated a "buy" rating and issued a $250.00 price objective on shares of Danaher in a report on Wednesday, July 23rd. Finally, Evercore ISI dropped their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research report on Tuesday, July 8th.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the firm's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 11.20% of the company's stock.

Hedge Funds Weigh In On Danaher

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Summit Global Investments boosted its stake in Danaher by 18.0% during the first quarter. Summit Global Investments now owns 1,057 shares of the conglomerate's stock worth $217,000 after acquiring an additional 161 shares in the last quarter. American National Bank & Trust boosted its position in shares of Danaher by 10.7% in the 1st quarter. American National Bank & Trust now owns 2,397 shares of the conglomerate's stock worth $491,000 after purchasing an additional 231 shares in the last quarter. Fiduciary Alliance LLC grew its stake in shares of Danaher by 3.3% in the 1st quarter. Fiduciary Alliance LLC now owns 34,971 shares of the conglomerate's stock worth $7,169,000 after buying an additional 1,119 shares during the last quarter. NBC Securities Inc. bought a new position in Danaher during the 1st quarter valued at approximately $176,000. Finally, Affiance Financial LLC raised its stake in Danaher by 54.6% during the first quarter. Affiance Financial LLC now owns 1,136 shares of the conglomerate's stock valued at $233,000 after buying an additional 401 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Price Performance

Shares of Danaher stock opened at $185.87 on Tuesday. The company's fifty day simple moving average is $199.39 and its two-hundred day simple moving average is $197.30. Danaher has a 12-month low of $171.00 and a 12-month high of $279.41. The firm has a market cap of $133.09 billion, a PE ratio of 39.55, a price-to-earnings-growth ratio of 2.63 and a beta of 0.75. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts expect that Danaher will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. Danaher's dividend payout ratio is 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.